LIRIC
Device
Clerio Vision, Inc
Total Payments
$4.9M
Transactions
4
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $4.9M | 4 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $4.5M | 2 | 90.9% |
| Unspecified | $450,654 | 2 | 9.1% |
Payments by Type
General
$4.5M
2 transactions
Research
$450,654
2 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Biological Impact of LIRIC of the cornea | Clerio Vision, Inc | $294,687 | 0 |
| PATHWAYS TOWARDS IN VIVO IRIS | Clerio Vision, Inc | $155,966 | 0 |
Top Doctors Receiving Payments for LIRIC
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Rochester, NY | $4.9M | 4 |
Ad
Manufacturing Companies
- Clerio Vision, Inc $4.9M
Product Information
- Type Device
- Total Payments $4.9M
- Total Doctors 0
- Transactions 4
About LIRIC
LIRIC is a device associated with $4.9M in payments to 0 healthcare providers, recorded across 4 transactions in the CMS Open Payments database. The primary manufacturer is Clerio Vision, Inc.
Payment data is available from 2021 to 2021. In 2021, $4.9M was paid across 4 transactions to 0 doctors.
The most common payment nature for LIRIC is "Royalty or License" ($4.5M, 90.9% of total).
LIRIC is associated with 2 research studies, including "Biological Impact of LIRIC of the cornea" ($294,687).